paraquat has been researched along with Cryptogenic Fibrosing Alveolitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Chen, Q; Fu, Z; Jiang, CM; Li, ZY; Li, ZZ; Liu, L; Shi, GY; Su, YM; Sui, BW; Sun, HQ; Yang, LZ; Zhang, W; Zhao, WC | 1 |
1 other study(ies) available for paraquat and Cryptogenic Fibrosing Alveolitis
| Article | Year |
|---|---|
Triptolide suppresses paraquat induced idiopathic pulmonary fibrosis by inhibiting TGFB1-dependent epithelial mesenchymal transition.
Topics: Animals; Cell Line; Cell Movement; Disease Models, Animal; Diterpenes; Drugs, Chinese Herbal; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxy Compounds; Humans; Idiopathic Pulmonary Fibrosis; Lung; Mice; Molecular Docking Simulation; Paraquat; Phenanthrenes; Protein Binding; Transforming Growth Factor beta1 | 2018 |